Using Informant and Performance Screening Methods to Detect Mild Cognitive Impairment and Dementia

Galvin, James E.

doi:10.1007/s13670-018-0236-2

Cited by 43 publications

(79 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Author in the paper [4] reviewed list of screening tests viz. Informant based and performance based Cognitive Screening Instruments (CSI) [4,5,9]. In informant-based CSI, Patient's close relative is asked questions covering various cognitive domains, patient's behaviour and day to day functionality, whereas in case of performance based CSIs, patient's self-assessment report is generated.…”

Section: Literature Review 21 Neuropsychological Assessmentmentioning

confidence: 99%

“…This test is easier to score and it takes about 10 minutes to administer, however it may not capture early stages of AD. MMSE is found to be the most extensively studied psychometric screening assessment of cognitive functioning [5][6][7][8][9][10]. It is a global cognitive functioning test covering major cognitive domains such as Orientation, attention, registration, language and praxis [8].…”

Section: Mini Mental State Examination (Mmse)mentioning

confidence: 99%

See 1 more Smart Citation

A Survey of Detection of Cognitive Impairment using Non-invasive Indicators

Karande¹,

Kulkarni²

2020

IJCA

View full text Add to dashboard Cite

Cognitive Impairment is a stage where a person faces difficulty in processing information, remembering, learning new things, concentrating or making decisions affecting their day to day life. These impairments range from mild to severe stage and in the long term they lead to Dementia and Alzheimer's disease. A person may have natural decline of cognition over the age and the nature of impairment changes from person to person. It's important to detect and measure these changes from time to time. The heterogeneous nature of Cognitive impairment and the natural decline of cognition over the age makes its detection more difficult. The review presented here is a study of various non-invasive methods such as neuropsychological tests, speech and eye dynamics used to measure cognitive and behavioural changes. These methods are used in preclinical frontline screening and diagnosis of impairment and they have their have their own relative accuracy when used separately. This review explores a multi-modal approach of combining these cognitive and behavioural markers to improve detection accuracy.

show abstract

Section: Literature Review 21 Neuropsychological Assessmentmentioning

confidence: 99%

Section: Mini Mental State Examination (Mmse)mentioning

confidence: 99%

A Survey of Detection of Cognitive Impairment using Non-invasive Indicators

Karande¹,

Kulkarni²

2020

IJCA

View full text Add to dashboard Cite

show abstract

“…In this model, an enhanced rate is billed on a CPT code and the billing practitioner shares the fee with the rest of the team, which can include a behavioral health care manager, psychologist, or psychiatric consultant. Incorporating a multi-stage model in which positive results from either a performance screen or an informant-based assessment is followed up by specialists (e.g., neurologist or neuropsychologist) can be of great value ( Galvin, 2018 ; Rosenbloom et al 2016 ). In a recent study by Grober and colleagues (2016) a two-step cognitive screening approach using a brief battery of neuropsychological tests followed by a more extensive battery of neuropsychological tests when the initial battery indicated impairment was highly beneficial in identifying primary care patients with early dementia.…”

Section: The Summit: Summary Of Issues Addressedmentioning

confidence: 99%

Population Health Solutions for Assessing Cognitive Impairment in Geriatric Patients

Perry

Lacritz

Roebuck-Spencer

et al. 2018

Innovation in Aging

View full text Add to dashboard Cite

In December 2017, the National Academy of Neuropsychology convened an interorganizational Summit on Population Health Solutions for Assessing Cognitive Impairment in Geriatric Patients in Denver, Colorado. The Summit brought together representatives of a broad range of stakeholders invested in the care of older adults to focus on the topic of cognitive health and aging. Summit participants speciﬁcally examined questions of who should be screened for cognitive impairment and how they should be screened in medical settings. This is important in the context of an acute illness given that the presence of cognitive impairment can have signiﬁcant implications for care and for the management of concomitant diseases as well as pose a major risk factor for dementia. Participants arrived at general principles to guide future screening approaches in medical populations and identiﬁed knowledge gaps to direct future research. Key learning points of the summit included: recognizing the importance of educating patients and healthcare providers about the value of assessing current and baseline cognition;emphasizing that any screening tool must be appropriately normalized and validated in the population in which it is used to obtain accurate information, including considerations of language, cultural factors, and education; andrecognizing the great potential, with appropriate caveats, of electronic health records to augment cognitive screening and tracking of changes in cognitive health over time.

show abstract

“…Sustained cognitive impairment and dementia are the main contributors to institutionalization in the older adult (Luppa et al, 2008) and represent substantial health care costs (The Healthy Brain Initiative: The Public Health Road Map for State and National Partnerships, 2013-2018. Given that healthcare resources are limited, informed decision making on health care management and efficient allocation of resources are important to minimize loss of opportunities (Handels, Wolfs, Aalten, Verhey, & Severens, 2013).…”

Section: Importance Of Cognition To Successful Agingmentioning

confidence: 99%

“…In this model, an enhanced rate is billed on a CPT code and the billing practitioner shares the fee with the rest of the team, which can include a behavioral health care manager, psychologist, or psychiatric consultant. Incorporating a multi-stage model in which positive results from either a performance screen or an informant-based assessment is followed up by specialists (e.g., neurologist or neuropsychologist) can be of great value (Galvin, 2018;Rosenbloom et al 2016). In a recent study by Grober and colleagues (2016) a two-step cognitive screening approach using a brief battery of neuropsychological tests followed by a more extensive battery of neuropsychological tests when the initial battery indicated impairment was highly beneficial in identifying primary care patients with early dementia.…”

Section: Current Trends: a Managed Care Perspectivementioning

confidence: 99%

Population Health Solutions for Assessing Cognitive Impairment in Geriatric Patients

Perry

Lacritz

Roebuck-Spencer³

et al. 2018

The Clinical Neuropsychologist

View full text Add to dashboard Cite

Colorado. The Summit brought together representatives of a broad range of stakeholders invested in the care of older adults to focus on the topic of cognitive health and aging. Summit participants specifically examined questions of who should be screened for cognitive impairment and how they should be screened in medical settings. This is important in the context of an acute illness given that the presence of cognitive impairment can have significant implications for care and for the management of concomitant diseases as well as pose a major risk factor for dementia. Participants arrived at general principles to guide future screening approaches in medical populations and identified knowledge gaps to direct future research. Key learning points of the summit included: recognizing the importance of educating patients and healthcare providers about the value of assessing current and baseline cognition; emphasizing that any screening tool must be appropriately normalized and validated in the population in which it is used to obtain accurate information, including considerations of language, cultural factors, and education; and recognizing the great potential, with appropriate caveats, of electronic health records to augment cognitive screening and tracking of changes in cognitive health over time.

show abstract

Using Informant and Performance Screening Methods to Detect Mild Cognitive Impairment and Dementia

Cited by 43 publications

References 34 publications

A Survey of Detection of Cognitive Impairment using Non-invasive Indicators

A Survey of Detection of Cognitive Impairment using Non-invasive Indicators

Population Health Solutions for Assessing Cognitive Impairment in Geriatric Patients

Population Health Solutions for Assessing Cognitive Impairment in Geriatric Patients

Contact Info

Product

Resources

About